kimoks 400 mg filmsko obložene tablete
alkaloid - int d.o.o. - moksifloksacin - filmsko obložena tableta - moksifloksacin 400 mg / 1 tableta - moksifloksacin
kimoks 400 mg filmsko obložene tablete
alkaloid - int d.o.o. - moksifloksacin - filmsko obložena tableta - moksifloksacin 400 mg / 1 tableta - moksifloksacin
kimoks 400 mg filmsko obložene tablete
alkaloid - int d.o.o. - moksifloksacin - filmsko obložena tableta - moksifloksacin 400 mg / 1 tableta - moksifloksacin
ceprotin
takeda manufacturing austria ag - človeški protein c - purpura fulminans; protein c deficiency - antitrombotična sredstva - ceprotin is indicated for prophylaxis and treatment of purpura fulminans coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.
banminth za konje
zoetis belgium sa -
sovrima
centocor b.v. - idebenon - friedreich ataxia - psychoanaleptics, - zdravljenje friedreichâs ataksije.
iblias
bayer ag - octocog alfa - hemofilija a - antihemoragije - zdravljenje in profilaksa krvavitve pri bolnikih s hemofilijo a (prirojeno pomanjkanje faktorja viii). iblias se lahko uporablja za vse starostne skupine.
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cepiva - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
zibor 25.000 i.e. anti-xa/ml raztopina za injiciranje v napolnjenih injekcijskih brizgah
frosst iberica s.a. - natrijev bemiparinat - raztopina za injiciranje v napolnjeni injekcijski brizgi - natrijev bemiparinat 10000 i.e. / 0,4 ml - bemiparin
zibor 25.000 i.e. anti-xa/ml raztopina za injiciranje v napolnjenih injekcijskih brizgah
frosst iberica s.a. - natrijev bemiparinat - raztopina za injiciranje v napolnjeni injekcijski brizgi - natrijev bemiparinat 10000 i.e. / 0,4 ml - bemiparin